ChartRow logo
$143.93-0.54%
as of market close, Sep 11, 2026
☾ AH
PeersMRNALLYUNHJNJABBVAMGN

MRK — Merck & Co. Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in MRK be worth today? →
MRK returns: By year · By month · By week · Trailing

Key stats

Price data

Price
$143.93
Change YTD
+38.74%
Next earnings
Oct 29, 2026
Market cap
355.1B
Enterprise value
403.1B
Shares outstanding
2.5B
52W low
$77.58
52W high
$156.92
From 52W high
-8.28%
From 52W low
+85.52%
52W range
84%
Beta
0.19

Volume

Rel volume
0.84×
30D volume
10.3M
30D $ vol
1.5B

Fundamentals

Sales (ttm)
66.6B
Sales/share
$26.98
EPS (ttm)
$1.28
FCF (ttm)
16.1B
FCF/share
$6.51
Book value/share
$17.00
Net margin
4.77%
ROE
7.57%
ROA
2.44%
Debt / equity
1.22×
Current ratio
1.32

Growth (CAGR, ttm) · 10Y

Sales
+4.65%+4.51%+8.68%+5.56%
Net income
-80.68%+0.66%-10.65%-4.70%
FCF
+9.12%+14.05%+17.76%+4.99%
Shares
-1.23%-0.93%-0.51%-1.13%

Per-share growth (CAGR, ttm) · 10Y

EPS
-80.30%+1.47%-10.23%-3.51%
Sales/share
+5.94%+5.50%+9.24%+6.76%
FCF/share
+10.47%+15.12%+18.34%+6.20%
Book value/share
-13.36%+3.68%+5.26%+0.81%
Dividend/share
+5.00%+5.27%+5.59%+6.27%
Price
+69.09%+9.84%+14.40%+9.21%
Total return
+74.75%+13.28%+18.02%+12.61%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
112.6×
Fwd P/E
15.7×
P/S (ttm)
5.3×
P/B (mrq)
8.5×
P/FCF (ttm)
22.1×
EV/EBITDA (fy)
29.4×
EV/Sales (ttm)
6.1×
FCF yield (ttm)
4.52%
Dividend yield (fwd)
2.33%
Dividend/share (fwd)
$3.36
Buyback yield (realized, 1y)
1.23%
Shareholder yield (realized, 1y)
5.42%
Buyback yield (cash, ttm)
1.18%
Shareholder yield (cash, ttm)
3.52%

Vs own 10Y history

P/E
92nd
P/S
95th
P/B
98th
P/FCF
46th

Bar = where today’s multiple sits in MRK’s own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

1D
-0.54%
5D
-5.52%
1M
+8.28%
3M
+20.04%
YTD
+38.74%
1Y
+77.01%
5Y
+118.13%

Financial statements

Open full MRK financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company-8.44%-0.65%
JNJJohnson & Johnson+2.31%-0.29%
ABBVAbbVie Inc.+3.36%+0.83%
UNHUnitedHealth Group Incorporated Common Stock (DE)-6.53%-2.37%
TMOThermo Fisher Scientific Inc.+1.13%+1.10%
AMGNAmgen Inc.-8.80%-1.34%
GILDGilead Sciences Inc.+5.78%-0.75%
ABTAbbott Laboratories-8.08%-1.36%

Merck & Co. Inc. (MRK) trades at $143.93 with a live price and an interactive chart covering 56+ years of daily price history, plus key valuation metrics. ChartRow also publishes MRK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MRK financial statements →